Nerivio For
Kids and Teens

Nerivio

For Teens

FDA
Approved
Treat &
Prevent
Ages
8 & Up
Migraine is a lifelong challenge

Your Child Deserves Effective, Pill-Free, and Needle-Free Relief

The Nerivio REN wearable is a pill-free, needle-free, non-disruptive prescribed acute and preventive treatment of migraine. Nerivio is proven to empower children and teens to consistently and effectively manage migraine, giving them more control over their daily lives.

Preventing Chronification:
The Role of Early, Safe, and Effective Migraine Care in Children and Teenagers

Treating migraine effectively at an early age is crucial to avoid long-term complications and possibility for chronification in the future.1 Yet treatment options for children and teenagers are limited; many medications given haven’t been tested for youth or may cause side effects that make it difficult to stay consistent with treatment.2

The Nerivio REN wearable meets this need by offering both preventive and acute migraine treatment through non-painful and safe stimulation. Nerivio harnesses the brain’s natural ability to control migraine pain and symptoms, even during class—all without systemic side effects or sedation.

1. Charles, J.A., Peterlin, B.L., Rapoport, A.M. et al. Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification. J Headache Pain 10, 227–233 (2009). https://doi.org/10.1007/s10194-009-0133-3
2. Freitag, Frederick & Schloemer, Fallon. (2016). Recent developments in the treatment of migraine in children and adolescents. Journal of Headache & Pain Management. 1. 10.4172/2472-1913.100009.

“The only preventive migraine therapy and the first non-drug acute treatment FDA-approved for children aged 8-11”

Real Voices. Real Stories.

Parents Share Their Nerivio Experiences

Read Nerivio users and parents share their migraine journeys and Nerivio’s impact on their lives.

No more visits to the nurse’s office for migraine medication intake

Treat migraine with the Nerivio REN wearable in class

The Nerivo REN wearable is not a medication and thus can be used in class. According to a study published in the journal “Children,” students coping with migraine were more likely to promptly treat their headaches if they used REN.

“By addressing the key barriers associated with migraine and the treatment of migraine at school, REN has the potential to transform migraine management in school-aged children and adolescents, and should be considered a first-line treatment option for students with headaches due to migraine.”
Andrew Hershey, MD, PhD
Director, Division of Neurology at
Cincinnati Children's
Proven Migraine Relief

Based on Strong Scientific Evidence

Clinical trials demonstrate that Nerivio provides consistent relief of pain and associated migraine symptoms. 
Data is based on 15,000 migraine patients studied in 16 different studies.

7 out of 10 patients
Achieved pain relief with Nerivio
(Hershey et al. 2020; Werner et al. 2024)
9 out of 10 patients
Demonstrated sustained pain relief and pain freedom at 24 hours
 (Hershey et al. 2020)
23% of patients
Achieved higher relief than with medication
 (Hershey et al. 2021)
7 out of 10 children
achieved pain relief with Nerivio
Werner et al. 2024
8 out of 10 children
experienced functional disability relief
Werner et al. 2024
5 of every 10 treatments
were not combined with medications
Werner et al. 2024

High five for freedom from medication complications and side effects

Drug-free and non-addictive
No systemic side effects
No pills, no needles
No risk of overuse
Use alone or alongside medication 

High five
Freedom from medication complications

Drug-free and non-addictive

No systemic side effects

No pills, no needles

No risk of overuse

Use alone or alongside medication 

High five
for a migraine treatment that fits teenagers' lives

Use in class, at home, or on the go

Non-disruptive and discreet 

Smartphone controlled

Preventive treatment reminders

Wireless, charging is not required